Dr Mads Krogsgaard Thomsen speaking to international media at the Novo Nordisk Favrholm campus in Denmark. He observed that once countries become obese, there is a lag time of about 10 years before the resultant increase in diabetes. - Novo Nordisk
Danish pharmaceutical company Novo Nordisk tackles both obesity and diabetes in their current drug pipeline.
Being overweight or obese has long been known to be a risk factor for type 2 diabetes.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
